OpenExamsFREE PRACTICE — ANY EXAM

Michigan Pharmacist — Requirements & Free Practice

US-MI · License preparation

300 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Loading selected examination banks…

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist

Michigan pharmacist license issued under Part 177 of the Public Health Code; licensure by examination, by endorsement, or relicensure.

Licensing authority: Michigan Board of Pharmacy, Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing · Application information

Pharmacist licensure by endorsement for an applicant licensed in a province of Canada

At least one of the following alternatives:

Attestation Of Law Knowledge
R 338.521(2)(f) / R 338.523(2)(b): provide an attestation to the department that the applicant has sufficient knowledge of the Public Health Code and the board's rules to competently practice pharmacy in this state (Michigan requires this attestation; its rules adopt no pharmacy jurisprudence examination).
Board Page Naplex Statement
The Board's Pharmacy NAPLEX Examination page states that endorsement applicants must have passed the NAPLEX; R 338.523(2)(a)(ii)(A) accepts the PEBC Qualifying Examination as an alternative.
Canadian Practice Billing
MCL 333.16186(1)(d): the applicant will perform the professional services billed in Michigan and third-party reimbursement requests will originate from the Michigan place of employment.
Education
R 338.523(2)(a)(ii)(B): completed educational requirements for a pharmacist license from a school of pharmacy accredited by the ACPE or the Canadian Council for Accreditation of Pharmacy Programs.
Eligibility
R 338.523(1) and (2)(a)(ii): the applicant has never held a pharmacist license in Michigan and holds a pharmacy license in good standing in Canada.
English Proficiency
R 338.7002b: demonstrate a working knowledge of English by an English-taught health professional program, 60 college credits from an English-speaking school, a board-approved credential evaluation (an FPGEC certification satisfies this), or a passing score on one of the listed language tests (Cambridge English, ECCE, ECPE, IELTS Academic, MET, OET, PTE Academic, TOEFL iBT, TOEIC).
General Licensure
MCL 333.16174: be 18 or more years of age, of good moral character, and establish that disciplinary proceedings are not pending and sanctions are not in force in any other jurisdiction; submit fingerprints for a criminal history check; disclose every health license held elsewhere with verification from each issuing entity.
Human Trafficking Training
R 338.511: one-time training in identifying victims of human trafficking.
Implicit Bias Training
R 338.7004(1): at least 2 hours of implicit bias training within the 5 years immediately preceding issuance of the license.
Opioid Awareness Training
R 338.3135 (as cited by R 338.521(2)(e) and R 338.523(2)(f)): training in opioids and other controlled substances awareness.
Pebc Alternative
R 338.523(2)(a)(ii)(A): instead of the NAPLEX, the applicant may have passed both part I and part II of the Pharmacy Examining Board of Canada Pharmacists Qualifying Examination (another country's national examination, recorded as a condition).
Practice Hours
R 338.523(2)(a)(ii)(C): if licensed in Canada for less than 1 year, at least 1,600 hours of pharmacy practice through an approved internship or practice as a pharmacist.
Pharmacist licensure by endorsement for an applicant licensed in another US state
No examination is required for this applicant pathway.
Attestation Of Law Knowledge
R 338.521(2)(f) / R 338.523(2)(b): provide an attestation to the department that the applicant has sufficient knowledge of the Public Health Code and the board's rules to competently practice pharmacy in this state (Michigan requires this attestation; its rules adopt no pharmacy jurisprudence examination).
Board Page Naplex Statement
The Board's Pharmacy NAPLEX Examination page (implementation material) states: "Applicants applying for a Michigan pharmacist license by examination or endorsement must have obtained a passing score on the NAPLEX prior to submitting an application for licensure to Michigan." R 338.523, the administrative rule setting the endorsement requirements, lists no examination for an applicant licensed in another state, so the route mounts no examination; the Board may still ask for NAPLEX score evidence as its page states.
Eligibility
R 338.523(1): the applicant has never held a pharmacist license in Michigan and is licensed in another state.
English Proficiency
R 338.7002b: demonstrate a working knowledge of English by an English-taught health professional program, 60 college credits from an English-speaking school, a board-approved credential evaluation (an FPGEC certification satisfies this), or a passing score on one of the listed language tests (Cambridge English, ECCE, ECPE, IELTS Academic, MET, OET, PTE Academic, TOEFL iBT, TOEIC).
General Licensure
MCL 333.16174: be 18 or more years of age, of good moral character, and establish that disciplinary proceedings are not pending and sanctions are not in force in any other jurisdiction; submit fingerprints for a criminal history check; disclose every health license held elsewhere with verification from each issuing entity.
Human Trafficking Training
R 338.511: one-time training in identifying victims of human trafficking.
Implicit Bias Training
R 338.7004(1): at least 2 hours of implicit bias training within the 5 years immediately preceding issuance of the license.
Interview
MCL 333.16186(2): the board may require the applicant to appear personally for an interview.
License In Good Standing
R 338.523(2)(a)(i): hold a pharmacist license in good standing in another state and submit the NABP licensure transfer report to the department.
Opioid Awareness Training
R 338.3135 (as cited by R 338.521(2)(e) and R 338.523(2)(f)): training in opioids and other controlled substances awareness.

Official no-examination sources

Effective from 2026-03-12.

Pharmacist licensure by examination
North American Pharmacist Licensure Examination
Attestation Of Law Knowledge
R 338.521(2)(f) / R 338.523(2)(b): provide an attestation to the department that the applicant has sufficient knowledge of the Public Health Code and the board's rules to competently practice pharmacy in this state (Michigan requires this attestation; its rules adopt no pharmacy jurisprudence examination).
Education
R 338.521(2)(a): obtain one of (i) a professional degree from a school of pharmacy accredited by the ACPE, (ii) an FPGEC certification from NABP (for graduates of pharmacy programs outside the United States), or (iii) an NABP score transfer if licensed in another state for 1 day to 1 year.
English Proficiency
R 338.7002b: demonstrate a working knowledge of English by an English-taught health professional program, 60 college credits from an English-speaking school, a board-approved credential evaluation (an FPGEC certification satisfies this), or a passing score on one of the listed language tests (Cambridge English, ECCE, ECPE, IELTS Academic, MET, OET, PTE Academic, TOEFL iBT, TOEIC).
Fpgec Certification
The FPGEC certification named by R 338.521(2)(a)(ii) is an NABP certification program; Michigan's rules and guide name the certification, not an examination, so it is recorded as an education alternative rather than an exam requirement.
General Licensure
MCL 333.16174: be 18 or more years of age, of good moral character, and establish that disciplinary proceedings are not pending and sanctions are not in force in any other jurisdiction; submit fingerprints for a criminal history check; disclose every health license held elsewhere with verification from each issuing entity.
Human Trafficking Training
R 338.511: one-time training in identifying victims of human trafficking.
Implicit Bias Training
R 338.7004(1): at least 2 hours of implicit bias training within the 5 years immediately preceding issuance of the license.
Internship
R 338.521(2)(c) and R 338.515: complete 1,600 internship hours; internship that includes the practice of pharmacy in Michigan requires an educational limited license.
Naplex Retake Limits
R 338.519(3)-(5): wait at least 45 days (or NABP's longer period) to retest; no more than 3 attempts in 12 months; after 3 failures a preapproved preparation course or instruction is required; no more than 5 attempts unless the applicant repeats an approved education program.
Naplex Timing
Licensing guide and Board NAPLEX page: the NAPLEX passing score must be obtained before the online application is submitted and must be sent to the Board by NABP.
Opioid Awareness Training
R 338.3135 (as cited by R 338.521(2)(e) and R 338.523(2)(f)): training in opioids and other controlled substances awareness.
Pharmacist relicensure after a lapse of 8 years or more, not currently licensed in another state or a Canadian province
North American Pharmacist Licensure Examination
Attestation Of Law Knowledge
R 338.525(1)(e): attestation of sufficient knowledge of the code and the board's rules.
Continuing Education
R 338.525(1)(d): 30 hours of continuing education satisfying R 338.3041 to R 338.3045 in the 2 years before application.
Eligibility
R 338.525(1): Michigan pharmacist license lapsed 8 or more years; applicant not currently licensed in good standing in another state or a province of Canada.
Naplex Window
R 338.525(1)(i): retake and pass the NAPLEX within 2 years before applying for relicensure, subject to the retake limits of R 338.519.
Other Requirements
R 338.525(1)(a)-(c), (f), (j): application and fee, good moral character, fingerprints, human trafficking, opioid awareness and implicit bias training, disclosure and verification of other licenses; R 338.7002b English proficiency applies to relicensure lapsed more than 3 years.
Practical Experience
R 338.525(1)(h) and (2): complete 400 hours of practical experience under the personal charge of a Michigan-licensed pharmacist within 6 months after being granted a non-renewable limited license (the guide's "Pharmacist Temp" license).
Pharmacist relicensure without examination (lapse of 3 years or less; lapse of more than 3 but less than 8 years; or any lapse while licensed in good standing in another state or a Canadian province)
No examination is required for this applicant pathway.
Continuing Education
R 338.525(1)(d) and (4)(d): 30 hours of continuing education satisfying R 338.3041 to R 338.3045 in the 2 years before application.
Eligibility
R 338.525(1) and (4): Michigan pharmacist license lapsed; the NAPLEX row of R 338.525(1) applies only to a lapse of 8 years or more without a current license in another state or Canadian province, which is the separate relicensure route.
Lapsed More Than3Less Than8Not Licensed Elsewhere
R 338.525(1)(g) and MCL 333.17733: complete 200 hours of practical experience under the personal charge of a Michigan-licensed pharmacist within 6 months after being granted a non-renewable limited license; attestation of law knowledge; fingerprints.
Licensed Elsewhere Lapsed More Than3
R 338.525(4): holds a current and valid pharmacist license in good standing in another state or Canadian province; fingerprints and attestation of law knowledge; no practical experience or examination row.
Other Requirements
Application and fee, good moral character, human trafficking, opioid awareness and implicit bias training, disclosure and verification of other licenses; R 338.7002b English proficiency applies to relicensure lapsed more than 3 years.

Official no-examination sources

Effective from 2026-03-12.

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources